Early perimenopause happens when hormonal shifts and cycle changes begin before age 45, earlier than the typical onset in the late 40s. The causes range from genetics and lifestyle factors to surgical interventions and environmental exposures. In many cases, more than one factor is at play.
What “Early” Actually Means
Perimenopause is the transition phase before menopause, when your ovaries gradually produce less of the hormones that regulate your cycle. Most people enter this phase in their mid-to-late 40s, but when it starts before 45, it’s considered early. If menopause itself arrives before age 40, that’s classified as premature menopause, a distinct condition sometimes called premature ovarian insufficiency.
The distinction matters because earlier onset is associated with different health risks down the line, including higher rates of heart disease, bone loss, and mood disorders. Understanding what triggered the early shift can help you and your healthcare provider plan accordingly.
Genetics Play the Largest Role
Your genes are the single biggest predictor of when perimenopause begins. Twin studies estimate that genetics account for 44 to 85% of the variation in when menopause occurs. If your mother or older sister went through menopause early, your odds of doing the same are substantially higher.
Researchers have identified specific genetic pathways involved. Some genes regulate the hormonal signaling between your brain and ovaries, the system that controls egg maturation and release each month. Others are involved in DNA repair within egg cells. When those repair mechanisms are less efficient, eggs accumulate damage faster and the ovarian reserve declines sooner. The combined effect of known genetic variants explains roughly 30% of the variation in early menopause cases, meaning there are likely additional genetic factors still being identified.
More than 60 individual genes have been linked to premature ovarian insufficiency specifically, with many of them clustered in pathways related to cell division during egg development. You can’t change your genetics, but knowing your family history gives you a meaningful signal about your own timeline.
Smoking Accelerates the Timeline
Smoking is the most well-documented lifestyle factor that pushes perimenopause earlier. People who smoke reach menopause about one to two years sooner than non-smokers. The chemicals in tobacco are directly toxic to egg cells and reduce blood flow to the ovaries, speeding up the natural decline in ovarian reserve.
This effect is dose-dependent: heavier and longer-term smoking does more damage. But even moderate smoking over several years can meaningfully shift the timeline. Quitting doesn’t reverse damage already done to the egg supply, but it does slow further loss.
Surgery and Gynecologic Procedures
Surgical removal of both ovaries (bilateral oophorectomy) causes immediate menopause regardless of age, since the organs producing your reproductive hormones are gone. But even a hysterectomy that leaves one or both ovaries in place can affect ovarian function over time.
When the uterus is removed but the ovaries are preserved, there’s no monthly period to signal what’s happening hormonally, making it difficult to recognize when ovarian function starts declining. Research from the Mayo Clinic has shown that people who undergo hysterectomy with ovarian conservation still face increased rates of heart disease, high cholesterol, high blood pressure, anxiety, and depression, outcomes that suggest ovarian function may be compromised sooner than expected. The surgery can disrupt blood supply to the ovaries or trigger subtle changes that accelerate their aging.
Cancer Treatments and Ovarian Damage
Chemotherapy and radiation therapy can damage the ovaries through several mechanisms, sometimes triggering early perimenopause during or after treatment. The ovaries contain a fixed number of immature eggs (the primordial follicle pool) that cannot be replaced once destroyed.
Chemotherapy drugs, particularly a class called alkylating agents, are the most harmful to fertility because they directly cause DNA breaks in egg cells. Other drugs damage eggs by disrupting the blood supply to ovarian tissue or by interfering with cell division. When larger, developing follicles are destroyed, the body compensates by activating immature eggs from its reserve. This rapid recruitment depletes the finite pool faster, potentially pushing someone into perimenopause years ahead of schedule.
Certain newer cancer therapies carry risks too. Some immunotherapy drugs can cause inflammation in the pituitary gland, the structure in your brain that sends hormonal signals to the ovaries. When that signaling breaks down, ovarian function can decline even though the ovaries themselves are intact. Radiation therapy directed at or near the pelvis poses a direct threat to ovarian tissue, with the degree of damage depending on the dose and field of treatment.
Chromosomal Conditions
Some people are born with chromosomal variations that lead to a shortened reproductive window. Turner syndrome, which affects roughly 1 in 2,500 females, is the most common example. In Turner syndrome, one of the two X chromosomes is either missing or partially altered, which accelerates the natural loss of egg cells that begins before birth.
About 30% of people with Turner syndrome experience some degree of puberty on their own, and 10 to 20% have a first period. But the egg supply is typically depleted much faster than usual, often resulting in premature ovarian insufficiency. People with mosaic forms of Turner syndrome, where some cells have the typical two X chromosomes and others don’t, tend to retain more ovarian function than those with a complete X chromosome deletion. Spontaneous pregnancy occurs in only 2 to 8% of Turner syndrome cases.
Environmental Chemical Exposures
Certain industrial chemicals that act as endocrine disruptors have been linked to earlier menopause. A large cross-sectional study using U.S. population data found that exposure to PCBs (polychlorinated biphenyls, found in older industrial products and contaminated fish) and phthalates (found widely in plastics, personal care products, and food packaging) was associated with a significantly earlier age of menopause.
These chemicals can interfere with hormonal signaling and may accelerate the depletion of the egg supply over years of low-level exposure. Notably, not all endocrine disruptors had the same effect. Dioxins and phytoestrogens (plant-based compounds with mild hormonal activity) were not associated with earlier menopause in the same study. The concern with PCBs and phthalates is their long half-lives in the body and the difficulty of avoiding them entirely, since exposure happens through diet, household products, and everyday plastic use.
How Hormonal Changes Are Measured
Two blood markers help gauge where you are in the transition. FSH (follicle-stimulating hormone) is produced by the brain to prompt the ovaries to develop eggs each month. As the ovaries become less responsive, the brain compensates by producing more FSH, so rising levels signal declining ovarian function. An FSH level above 40 mIU/mL before typical menopause age is used to diagnose premature ovarian failure.
AMH (anti-Müllerian hormone) is produced by the remaining egg-containing follicles and gives a snapshot of ovarian reserve. Expected AMH levels decline naturally with age: around 2.1 ng/mL or higher before age 33, dropping to about 0.5 ng/mL by the early 40s. Values significantly below these benchmarks for your age can indicate an accelerated decline. AMH has the advantage of being measurable on any day of your cycle, while FSH is most informative when tested on day three of your period.
Neither test alone confirms early perimenopause. Symptoms like irregular cycles, hot flashes, sleep disruption, and mood changes are typically what prompt testing in the first place, and hormone levels are interpreted alongside those patterns.